Literature DB >> 15485632

A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome.

Hongmei Li1, Meifang Dai, Yuan Zhuang.   

Abstract

Sjogren's syndrome is an autoimmune disease with clinical hallmarks of keratoconjunctivitis sicca (dry eyes) and xerostomia (dry mouth). The genetic basis of this autoimmune disease is poorly understood. Id3 is an immediate early-response gene in growth regulation and is involved in TCR-mediated T cell selection during T cell development. Here, we show that Id3-deficient mice develop many disease symptoms found in primary Sjogren's syndrome patients including dry eyes and mouth, lymphocyte infiltration in lachrymal and salivary glands, and development of anti-Ro and anti-La antibodies. Adoptive transfer experiment indicated a T cell intrinsic role for Id3 in the development of Sjogren's symptoms. Furthermore, genetic ablation of T cells or neonatal 3 day thymectomy in Id3-deficient mice showed a rescue of disease symptoms, suggesting a thymic origin of autoimmune T cells. Thus, this study establishes a critical connection between Id3-mediated T cell development and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485632     DOI: 10.1016/j.immuni.2004.08.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  66 in total

1.  An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse.

Authors:  Jason J DeVoss; Norbert P LeClair; Yafei Hou; Navdeep K Grewal; Kellsey P Johannes; Wen Lu; Ting Yang; Craig Meagher; Lawrence Fong; Erich C Strauss; Mark S Anderson
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

2.  Two histone/protein acetyltransferases, CBP and p300, are indispensable for Foxp3+ T-regulatory cell development and function.

Authors:  Yujie Liu; Liqing Wang; Rongxiang Han; Ulf H Beier; Tatiana Akimova; Tricia Bhatti; Haiyan Xiao; Philip A Cole; Paul K Brindle; Wayne W Hancock
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

Review 3.  The molecular mechanisms of Foxp3 gene regulation.

Authors:  Takashi Maruyama; Joanne E Konkel; Brian F Zamarron; WanJun Chen
Journal:  Semin Immunol       Date:  2011-07-12       Impact factor: 11.130

Review 4.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

5.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

Review 6.  Remembering one's ID/E-ntity: E/ID protein regulation of T cell memory.

Authors:  Kyla D Omilusik; Laura A Shaw; Ananda W Goldrath
Journal:  Curr Opin Immunol       Date:  2013-10-01       Impact factor: 7.486

7.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.

Authors:  Jean S Oak; Jonathan A Deane; Michael G Kharas; Ji Luo; Thomas E Lane; Lewis C Cantley; David A Fruman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

8.  B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.

Authors:  Ikuko Hayakawa; Thomas F Tedder; Yuan Zhuang
Journal:  Immunology       Date:  2007-04-30       Impact factor: 7.397

9.  Selecting highly sensitive non-obese diabetic mice for improving the study of Sjögren's syndrome.

Authors:  Weibao Xiao; Yalan Wu; Jingfa Zhang; Wen Ye; Guo-Tong Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-23       Impact factor: 3.117

10.  Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition.

Authors:  Máire E Doyle; Lori Boggs; Robert Attia; Lauren R Cooper; Daniel R Saban; Cuong Q Nguyen; Ammon B Peck
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.